Yabao Pharmaceutical Group Co., Ltd (SHA:600351)
6.77
+0.07 (1.04%)
Feb 27, 2026, 3:00 PM CST
12.09% (1Y)
| Market Cap | 4.64B +7.5% |
| Revenue (ttm) | 2.27B -19.7% |
| Net Income | 222.85M +1.0% |
| EPS | 0.32 +4.8% |
| Shares Out | 692.00M |
| PE Ratio | 21.22 |
| Forward PE | n/a |
| Dividend | 0.40 (5.98%) |
| Ex-Dividend Date | Feb 6, 2026 |
| Volume | 9,405,092 |
| Average Volume | 12,467,485 |
| Open | 6.70 |
| Previous Close | 6.70 |
| Day's Range | 6.68 - 6.77 |
| 52-Week Range | 5.35 - 8.68 |
| Beta | 0.11 |
| RSI | 48.33 |
| Earnings Date | Apr 25, 2026 |